FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

ZBH

Zimmer BiometNYSE · Health Care Equipment · Health Care
Previous close
96.78
Change
−1.63 / −1.66%
FinDog View
Neutral
52-Week Range
79.12 – 106.88
P/E (TTM)
22.1
Forward P/E
10.8
Based on consensus earnings for the next 12 months
Market Cap
$18.4B
1M
−1.45%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.9M / 2.0M
0.95× average

Price History

Closing price · USD1M6M1Y5Y
708090100110FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 Earnings2025-092025-122026-032026-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 23.91M6M1Y5Y
1020304050602023-082024-052025-032025-122026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-08-05$2.2B2.07 / 2.03−0.99%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-04-28$2.1B2.09 / 1.88−3.30%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-10—— / —+4.61%Pending
FY2025 Q3
Quarter ended 2025-09
2025-11-05—— / —+1.10%Pending
FY2025 Q2
Quarter ended 2025-06
2025-08-07—— / —+0.84%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-05—— / —+1.98%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 25 of its 5-year rangeCheap
5-year range 20.4 – 52.6 · Median 23.9
Last 4 quarters: $751M in buybacks + $188M in dividends, 5.11% of market cap combined
P/E (TTM)
22.1
P/B
1.4
P/S
2.1
Dividend Yield
1.04%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.1% on average on the first trading day after, rising 4 times
Most recent −0.99%
Volatility & Correlation
1-year beta 0.22 · Correlation with S&P 500 0.09Low beta
Annualized volatility 32% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 2 · $0.82MNet selling $0.82M
  • 09-11Thornal Kevin RGrp Pres-Global BusinessSell$0.53M5,691 shares · Avg price 92.95
  • 09-04Phipps Chad FSee remarks below.Sell$0.30M3,000 shares · Avg price 98.35
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q22.18+4.8%70.8%0.330.200.391.03
FY2026 Q12.09+9.3%72.4%0.370.240.321.22
FY2025 Q42.24+10.9%64.7%0.150.140.440.71
FY2025 Q32.00+9.7%72.1%0.350.230.361.16
FY2025 Q22.08+7.0%71.5%0.300.150.330.77
FY2025 Q11.91+1.1%71.2%0.290.180.340.91
FY2024 Q42.02+4.3%71.0%0.390.240.451.18
FY2024 Q31.82+4.0%70.5%0.280.250.351.23
FY2024 Q21.94+3.9%71.5%0.350.240.321.18
FY2024 Q11.89+3.2%72.9%0.270.170.170.84
FY2023 Q41.94+6.3%72.2%0.350.420.532.00
FY2023 Q31.75+5.0%70.4%0.270.160.250.77

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
ZBHZimmer Biomet$18.4B22.1+4.8%70.8%−1.45%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare